Crossref
Smoking cessation products and major congenital malformations
Drug and Therapeutics Bulletin · 2025
DOI: 10.1136/dtb.2025.000033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Therapeutics Bulletin, 2025. Hauptthemen laut MEDLINE: Abnormalities, Drug-Induced, Congenital Abnormalities, Prenatal Exposure Delayed Effects, Smoking Cessation. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Overview of: Tran DT, Cohen JM, Donald S, et al . Risk of Major Congenital Malformations Following Prenatal Exposure to Smoking Cessation Medicines. JAMA Intern Med 2025;185:656-67.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Abnormalities, Drug-InducedCongenital AbnormalitiesPrenatal Exposure Delayed EffectsSmoking CessationSmoking Cessation AgentsTobacco Use Cessation DevicesFemaleHumansPregnancy
Stichwörter der Autor:innen
Drug-Related Side Effects and Adverse ReactionsHealth Care Quality, Access, and Evaluation
Substanzen
Smoking Cessation Agents
Zitieren
APA
(2025). Smoking cessation products and major congenital malformations. Drug and Therapeutics Bulletin. https://doi.org/10.1136/dtb.2025.000033
Vancouver
Smoking cessation products and major congenital malformations. Drug and Therapeutics Bulletin. 2025. doi:10.1136/dtb.2025.000033
BibTeX
@article{euvimed2025,
title = {Smoking cessation products and major congenital malformations},
journal = {Drug and Therapeutics Bulletin},
year = {2025},
doi = {10.1136/dtb.2025.000033}
}
EUVIMED